Xenetic Biosciences XBIO
NASDAQ XBIO
$1.97 -0.05 (-2.23%)
As of: Oct 21, 2026 · 11:35 AM EDT

Xenetic Biosciences (XBIO) Acquisitions (2014)

Updated

Xenetic Biosciences (XBIO) reported Acquisitions of $43,502 for FY2014.

Analysis

Xenetic Biosciences (XBIO) Acquisitions (2014) Analysis & Trends

  • According to Business Quant data, Acquisitions came in at -$349.00 in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,133.90 Bn 1,102.48 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 616.46 Bn 534.99 Bn 17.26 Bn -17.24 Bn
3 AbbVie 501.26 Bn 474.37 Bn 12.70 Bn -
4 Merck 367.00 Bn 321.38 Bn 12.21 Bn -
5 Novartis Ag 297.91 Bn 261.90 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn -
7 Amgen 235.82 Bn 191.22 Bn 7.24 Bn -
8 Gilead Sciences 190.63 Bn 164.82 Bn 6.22 Bn 11.21 Bn
9 Pfizer 169.35 Bn 115.99 Bn 10.94 Bn -
10 Xenetic Biosciences 4.52 Mn -21.30 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 -43,502.00
API Access

Xenetic Biosciences Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=XBIO&period=max&api_key=YOUR_API_KEY